BUSINESS

• Mochida Set to Achieve 10 Billion Yen Generic Sales in FY2015
  January 27, 2016

• MSD Joins with Venture Capital to Offer BD Support for Health-Tech Startups
  January 27, 2016

• Mundipharma to Merge Spectrum Unit in March, Become MAH for Zevalin
  January 26, 2016

• Kyowa Kirin to Market Sandoz’s Rituximab Biosimilar in Japan
  January 26, 2016

• Dispensing Pharmacies Worried about Reversal of Delivery and NHI Prices Following Re-Pricing of Gilead’s “Huge Seller” Hep C Drugs
  January 21, 2016

• Maruho, Galderma Team Up to Develop, Market Skin Treatments in Japan
  January 19, 2016

• Toa Eiyo to Take Over Astellas’s Marketing Authorization for Cibenol
  January 19, 2016

• GSK to Resume Shipment of Hep B Drug Tenozet
  January 18, 2016

• Novartis Partners with Meiji Seika Pharma to Promote COPD Drugs
  January 18, 2016

• Ethical Drug Sales Jump 15.2% in November: Crecon Report
  January 18, 2016

• MSD Renews Call for Reinstating Govt’s HPV Vaccine Promotion after WHO Statement
  January 15, 2016

• Ono Files Etelcalcetide for Secondary Hyperparathyroidism in Japan
  January 15, 2016

• Ribomic Inks New Agreement with Otsuka on Midkine Aptamer; Otsuka to Decide on In-Licensing by Year-End
  January 15, 2016

• INDEE Medical Obtains Exclusive Distribution Rights in Japan for Autologous Epidermis Transplant Kit from Australian Company
  January 15, 2016

• Weber Says Takeda Made “Big Decision” to Pull Plug on Metabolic R&D
  January 14, 2016

• Iwaki Top Brass to Return Remunerations over Embezzlement Issue
  January 14, 2016

• Mundipharma Looks to Double Japan Sales of OTC Isodine Products in 5 Years
  January 14, 2016

• Lenvima Filed for RCC Indication in EU: Eisai
  January 13, 2016

• Enbrel Biosimilar Meets Equivalence Criteria in Global PIII: Daiichi Sankyo
  January 13, 2016

• Takeda Allies with Canada’s enGene to Develop GI Disease Therapies
  January 13, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 495
• 496
• 497
• 498
• 499
• 500
• 501
• 502
• 503
• …
• Next ›
• 最終 »